483 related articles for article (PubMed ID: 21870977)
1. A new era for anticoagulation in atrial fibrillation.
Mega JL
N Engl J Med; 2011 Sep; 365(11):1052-4. PubMed ID: 21870977
[No Abstract] [Full Text] [Related]
2. What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
Ahrens I; Lip GY; Peter K
Thromb Haemost; 2011 Apr; 105(4):574-8. PubMed ID: 21225102
[No Abstract] [Full Text] [Related]
3. New directions in anticoagulation.
Alpert JS
Am J Med; 2012 Mar; 125(3):217-8. PubMed ID: 22340912
[No Abstract] [Full Text] [Related]
4. What are the new therapeutic alternatives to warfarin in atrial fibrillation?
Kamran SH; Muzammil SM; Kamal AK
J Pak Med Assoc; 2013 Jan; 63(1):129-30. PubMed ID: 23865151
[No Abstract] [Full Text] [Related]
5. [New anticoagulants: better knowledge, better prescriptions].
Boehlen F; de Moerloose P
Rev Med Suisse; 2012 Jan; 8(324):96-9. PubMed ID: 23185817
[TBL] [Abstract][Full Text] [Related]
6. Novel oral anticoagulants in secondary prevention of stroke.
Diener HC; Easton JD; Hankey GJ; Hart RG
Best Pract Res Clin Haematol; 2013 Jun; 26(2):131-9. PubMed ID: 23953901
[TBL] [Abstract][Full Text] [Related]
7. Contra: "New oral anticoagulants should not be used as 1st choice for secondary stroke prevention in atrial fibrillation".
Stöllberger C; Finsterer J
Thromb Haemost; 2013 Sep; 110(3):496-500. PubMed ID: 23803875
[No Abstract] [Full Text] [Related]
8. Atrial fibrillation choices. Picking an anti-clotting drug.
Mayo Clin Health Lett; 2014 Jun; 32(6):4-5. PubMed ID: 25029747
[No Abstract] [Full Text] [Related]
9. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
10. [Atrial fibrillation: what the GP needs to know].
Diener HC; Kaeufer T; Bode C
MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
[No Abstract] [Full Text] [Related]
11. Help prevent Afib-related stroke. New anticoagulants for atrial fibrillation prove as effective, or even better than, warfarin--and easier to use.
Duke Med Health News; 2014 Sep; 20(9):3. PubMed ID: 25358137
[No Abstract] [Full Text] [Related]
12. Defining non-valvular atrial fibrillation while selecting anticoagulation therapy.
Garg P; Ripley DP
Br J Hosp Med (Lond); 2015 Feb; 76(2):66-7. PubMed ID: 25671468
[No Abstract] [Full Text] [Related]
13. Pro: "The novel oral anticoagulants should be used as 1st choice for secondary prevention in patients with atrial fibrillation.".
Diener HC
Thromb Haemost; 2013 Sep; 110(3):493-5. PubMed ID: 23803957
[No Abstract] [Full Text] [Related]
14. Treatment of atrial fibrillation.
Med Lett Drugs Ther; 2014 Jul; 56(1446):53-8. PubMed ID: 25046325
[No Abstract] [Full Text] [Related]
15. Novel oral anticoagulants in non-valvular atrial fibrillation.
Potpara TS; Lip GY
Best Pract Res Clin Haematol; 2013 Jun; 26(2):115-29. PubMed ID: 23953900
[TBL] [Abstract][Full Text] [Related]
16. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation: dawn of a new era.
Contractor T; Levin V; Martinez MW; Marchlinski FE
Postgrad Med; 2013 Jan; 125(1):34-44. PubMed ID: 23391669
[TBL] [Abstract][Full Text] [Related]
17. New anticoagulants (dabigatran, apixaban, rivaroxaban) for stroke prevention in atrial fibrillation.
Aguilar MI; Kuo RS; Freeman WD
Neurol Clin; 2013 Aug; 31(3):659-75. PubMed ID: 23896498
[TBL] [Abstract][Full Text] [Related]
18. Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.
Morales-Vidal S; Schneck MJ; Flaster M; Biller J
Expert Rev Neurother; 2012 Feb; 12(2):179-89; quiz 190. PubMed ID: 22288673
[TBL] [Abstract][Full Text] [Related]
19. Outpatient management of oral anticoagulation in atrial fibrillation.
Manning JA
Crit Care Nurs Clin North Am; 2013 Dec; 25(4):481-7, vi. PubMed ID: 24267284
[TBL] [Abstract][Full Text] [Related]
20. [New oral anticoagulants are as safe in elderly patients as conventional drugs].
Steurer J
Praxis (Bern 1994); 2014 Aug; 103(17):1032. PubMed ID: 25146949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
